DFDelphine Feldmann

Delphine Feldmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Delphine Feldmann has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Albert Iron

    Laboratoire de Génétique Moléculaire, Hôpital Pellegrin, Bordeaux, France

    1 shared publication
  • Christine Clavel

    Unité de Biologie Cellulaire et Moléculaire, CHU, Hôpital Maison Blanche, Reims, France

    1 shared publication
  • Claude Ferec

    Laboratoire de Génétique Moléculaire et d'Histocompatibilité, CHU Morvan, Brest, France

    1 shared publication
  • Cécile Cazeneuve

    Service de Biochimie et deGénétique, Hôpital Henri Mondor, AP‐HP, Créteil, France

    1 shared publication
  • Dominique Bozon

    Laboratoire de Biochimie Pédiatrique, Hôpital Debrousse, Lyon, France

    1 shared publication
  • Emmanuelle Girodon

    Service de Biochimie et deGénétique, Hôpital Henri Mondor, AP‐HP, Créteil, France

    1 shared publication

Latest Publications

  • Open Access

    CFTR genotypes in patients with normal or borderline sweat chloride levels

    by Delphine Feldmann, Remy Couderc, Marie-Pierre Audrezet, Claude Ferec, Thierry Bienvenu, Marie Desgeorges, Mireille Claustres, Martine Blayau, Dominique Bozon, Marie-Claire Malinge, et al.

    In recent years, some patients bearing “atypical” forms of cystic fibrosis (CF) with normal sweat chloride concentrations have been described. To identify the spectrum of mutant combinations causing such atypical CF, we collected the results of CFTR (ABCC7) mutation analysis from 15 laboratories. Thirty patients with one or more typical symptoms of the disease associated with normal or borderline sweat chloride levels and bearing two CFTR mutations were selected. Phenotypes and genotypes of these 30 patients are described. A total of 18 different CFTR mutations were observed in the 60 chromosomes analysed. F508del was present in 31.6 % of the mutated chromosomes and 3849+10kbC>T in 13.3 %. R117H, D1152H, L206W, 3272‐26A>G, S1235R, G149R, R1070W, S945L, and the poly‐T tract variation commonly called IVS8‐5T were also observed. The relative frequency of CFTR mutations clearly differed from that observed in typical CF patients or in CBAVD patients with the same ethnic origin. A mild genotype with one or two mild or variable mutations was observed in all the patients. These findings improve our understanding of the distribution of CFTR alleles in CF with normal or borderline sweat chloride concentrations and will facilitate the development of more sensitive CFTR mutation screening.